autoantibody
Showing 26 - 50 of 397
Type1diabetes, Diabetes, Type 1, Type1 Diabetes Trial in Milwaukee (Blood Collection)
Recruiting
- Type1diabetes
- +3 more
- Blood Collection
-
Milwaukee, WisconsinMedical College of Wisconsin
Dec 15, 2022
Systemic Lupus Erythematosus, Pulmonary Arterial Hypertension Trial in Beijing (Rituximab)
Not yet recruiting
- Systemic Lupus Erythematosus
- Pulmonary Arterial Hypertension
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Apr 13, 2023
Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome Trial in Orange (CAB-201 following preconditioning
Recruiting
- Idiopathic Inflammatory Myopathy
- +3 more
- CAB-201 following preconditioning with fludarabine and cyclophosphamide
-
Orange, CaliforniaUniversity of California Irvine
Nov 30, 2023
Congenital Heart Block, Neonatal Lupus, Autoantibody-associated Heart Block Trial in Livingston, New York (intravenous immune
Completed
- Congenital Heart Block
- +2 more
- intravenous immune globulin (IVIG)
-
Livingston, New Jersey
- +1 more
Sep 26, 2019
Healthy Participants, Rheumatoid Arthritis (RA) Prevention Trial in United States (Hydroxychloroquine, HCQ Placebo)
Completed
- Healthy Participants
- Rheumatoid Arthritis (RA) Prevention
- Hydroxychloroquine
- HCQ Placebo
-
Los Angeles, California
- +12 more
Dec 14, 2022
PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive
Not yet recruiting
- Autoimmune Hepatitis
- Autoimmune Liver Disease
- polyreactive immunoglobulin G
- (no location specified)
Apr 11, 2023
Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Diabetes, High Risk Trial in Canada, Germany, United States
Completed
- Autoantibody Positive
- +3 more
- Teplizumab
- Placebo infusion
-
San Francisco, California
- +18 more
Jul 21, 2020
Systemic Lupus Erythematosus Trial in Shanghai (Relma-cel)
Recruiting
- Systemic Lupus Erythematosus
- Relma-cel
-
Shanghai, ChinaRelma-cel Medical
Mar 12, 2023
Pilot Study of Gut Commensals in Antiphospholipid Syndrome
Active, not recruiting
- Antiphospholipid Syndrome (APS)
-
New Haven, ConnecticutYale University School of Medicine; Yale-New Haven Hospital
Apr 25, 2022
Aplastic Anemia, Platelet Transfusion Refractoriness Trial in Tianjin (Daratumumab)
Recruiting
- Aplastic Anemia
- Platelet Transfusion Refractoriness
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Apr 25, 2023
Type 1 Diabetes Recurrence in Pancreas Transplants
Recruiting
- Diabetes Mellitus, Type 1
-
Miami, FloridaUniversity of Miami Miller School of Medicine Transplant Clinic
Apr 4, 2022
Vitamin D on Hashimoto's Thyroiditis
Not yet recruiting
- Hashimoto Thyroiditis
- Vitamin D Drops
- (no location specified)
May 22, 2023
Security Efficacy COVID-19 Vaccination
Completed
- Autoimmune State
- SARS-CoV-2 Infection
- Blood sampling
-
Milan, ItalyIstituto Auxologico Italiano IRCCS
Feb 23, 2023
Pattern of Autoimmune Hepatitis in Children In Sohag University
Not yet recruiting
- Autoimmune Hepatitis
- liver biobsy
-
Sohag, EgyptSohag university Hospital
Aug 27, 2023
Type 1 Diabetes, Diabetes, Type 1 Trial in Miami (CELZ-201 Administration, Control Group)
Not yet recruiting
- Type 1 Diabetes
- Diabetes Mellitus, Type 1
- CELZ-201 Administration
- Control Group
-
Miami, FloridaDiabetes Research Institute, University of Miami Miller School o
Nov 15, 2022
Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)
Recruiting
- Breast Cancer
- +12 more
- Checkpoint Blockade, Immune
-
Brussel, Anderlecht, BelgiumInstitut Jules Bordet
Jul 1, 2022
Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) Trial in Zhongshan (BCMA-CD19 cCAR T cells)
Recruiting
- Relapsed/Refractory, Systemic Lupus Erythematosus (SLE)
- BCMA-CD19 cCAR T cells
-
Zhongshan, Guangdong, ChinaZhongshan People's Hospital
Jul 23, 2022
Systemic Lupus Erythematosus in Gullah Health
Recruiting
- Systemic Lupus Erythematosus
-
Charleston, South CarolinaMedical University of South Carolina
Oct 17, 2022
Generalized Myasthenia Gravis Trial (rozanolixizumab)
Not yet recruiting
- Generalized Myasthenia Gravis
- (no location specified)
Nov 28, 2023
TrialNet Pathway to Prevention of T1D
Recruiting
- Diabetes Mellitus, Type 1
-
Orange, California
- +21 more
Feb 18, 2022
Autoimmune Diseases Trial in Shenzhen, Guilin (4SCAR T cells)
Recruiting
- Autoimmune Diseases
- 4SCAR T cells
-
Shenzhen, Guangdong, China
- +1 more
Jul 17, 2022
Controls and Healthy Vasculature Initiative
Recruiting
- Vascular And Immunologic Diseases
- Healthy Volunteers
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Boston (CABA-201)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- CABA-201
-
Boston, MassachusettsMassachusetts General Hospital
Nov 7, 2023